Jiangsu Peptide Energy, based in China, develops advanced peptide-based biomaterials for life science research. The company has introduced two core product lines the ELPmatrix™ elastin like polypeptide (ELP) hydrogel series and the PoroGenex™ macroporous hydrogel series which have been validated across multiple applications, including stem cell culture, organoid models, drug screening, and cell injection. These hydrogels demonstrate strong biocompatibility along with precise control over material structure and performance.
